☰

Jingyu Yu, Ph.D. - Publications

Affiliations: 
University of Michigan, Ann Arbor, Ann Arbor, MI 
Area:
Pharmaceutical Sciences, Drug Biocrystals, Pharmacokinetics, Formulation, Drug Targeting, Drug Delivery
Tree Info Similar researchers PubMed Report error

9 high-probability publications. We are testing a new system for linking publications to authors. You can help! If you notice any inaccuracies, please sign in and mark papers as correct or incorrect matches. If you identify any major omissions or other inaccuracies in the publication list, please let us know.

Year Citation  Score
2021 Bi Y, Liu J, Li F, Yu J, Bhattaram A, Bewernitz M, Li RJ, Ahn J, Earp J, Ma L, Zhuang L, Yang Y, Zhang X, Zhu H, Wang Y. Model-Informed Drug Development in Pediatric Dose Selection. Journal of Clinical Pharmacology. 61: S60-S69. PMID 34185906 DOI: 10.1002/jcph.1848  0.42
2020 Narayan P, Prowell TM, Gao JJ, Fernandes LL, Li E, Jiang X, Qiu J, Fan J, Song P, Yu J, Zhang X, King-Kallimanis BL, Chen W, Ricks TK, Gong Y, et al. FDA Approval Summary: Alpelisib plus fulvestrant for patients with HR-positive, HER2-negative, PIK3CA-mutated, advanced or metastatic breast cancer. Clinical Cancer Research : An Official Journal of the American Association For Cancer Research. PMID 33168657 DOI: 10.1158/1078-0432.CCR-20-3652  0.348
2020 Shah M, Wedam S, Cheng J, Fiero MH, Xia H, Li F, Fan J, Zhang X, Yu J, Song P, Chen W, Ricks TK, Chen XH, Goldberg KB, Gong Y, et al. FDA Approval Summary: Tucatinib for the Treatment of Patients with Advanced or Metastatic HER2-Positive Breast Cancer. Clinical Cancer Research : An Official Journal of the American Association For Cancer Research. PMID 33055172 DOI: 10.1158/1078-0432.CCR-20-2701  0.375
2019 Bi Y, Liu J, Li L, Yu J, Bhattaram A, Bewernitz M, Li RJ, Liu C, Earp J, Ma L, Zhuang L, Yang Y, Zhang X, Zhu H, Wang Y. Role of Model-Informed Drug Development in Pediatric Drug Development, Regulatory Evaluation, and Labeling. Journal of Clinical Pharmacology. 59: S104-S111. PMID 31502691 DOI: 10.1002/jcph.1478  0.42
2018 Singh H, Walker AJ, Amiri-Kordestani L, Cheng J, Tang S, Balcazar P, Barnett-Ringgold K, Palmby TR, Cao X, Zheng N, Liu Q, Yu J, Pierce WF, Daniels SR, Sridhara R, et al. U.S. Food and Drug Administration Approval: Neratinib for the Extended Adjuvant Treatment of Early Stage HER2-Positive Breast Cancer. Clinical Cancer Research : An Official Journal of the American Association For Cancer Research. PMID 29523624 DOI: 10.1158/1078-0432.CCR-17-3628  0.363
2014 Min KA, Zhang X, Yu JY, Rosania GR. Computational approaches to analyse and predict small molecule transport and distribution at cellular and subcellular levels. Biopharmaceutics & Drug Disposition. 35: 15-32. PMID 24218242 DOI: 10.1002/Bdd.1879  0.664
2013 Min KA, Talattof A, Tsume Y, Stringer KA, Yu JY, Lim DH, Rosania GR. The extracellular microenvironment explains variations in passive drug transport across different airway epithelial cell types. Pharmaceutical Research. 30: 2118-32. PMID 23708857 DOI: 10.1007/S11095-013-1069-5  0.66
2012 Yu JY, Zheng N, Mane G, Min KA, Hinestroza JP, Zhu H, Stringer KA, Rosania GR. A cell-based computational modeling approach for developing site-directed molecular probes. Plos Computational Biology. 8: e1002378. PMID 22383866 DOI: 10.1371/Journal.Pcbi.1002378  0.665
2010 Yu JY, Rosania GR. Cell-based multiscale computational modeling of small molecule absorption and retention in the lungs. Pharmaceutical Research. 27: 457-67. PMID 20099073 DOI: 10.1007/S11095-009-0034-9  0.623
Show low-probability matches.